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Abstract: Pharmaceutical sodium salts are prone to incorporate 
water into their crystal structure. The model compound diatrizoic acid 
monosodium salt, an X-ray contrast agent, has been investigated in 
depth towards its interaction with water in the solid state. Five 
hydrates with water content ranging from 0.3 to 8 molar equivalents 
of water show a high degree of interconvertibility, stoichiometric and 
non-stoichiometric behaviour, and potential of amorphisation during 
release of water. A DMSO/water mixed solvate further highlights the 
high attraction of this salt to incorporate water. All incorporated solvent 
coordinates to the sodium cation and can further interact and stabilise 
the respective crystal forms by hydrogen bonding. DTS thus highlights 
the importance of an in-depth investigation of sodium salts used 
pharmaceutically to guarantee dose uniformity and stability of final 
formulation. 
Introduction 
The challenge to optimize the physical and chemical properties of 
a new active pharmaceutical ingredient (API), such as flowability, 
hardness, stability and solubility, is an everyday challenge for the 
pharmaceutical industry. Many compounds as synthesized are 
non-optimal materials for manufacturing and patient safety, and 
thus further steps are taken, e.g. change of crystal form, co-
crystallisation or salt formation. Especially for molecules showing 
low to very low solubility in water, salt formation is the most 
preferable strategy in the presence of an ionisable or protonatable 
moiety in the molecule. Traditionally, the salt-forming agents are 
chosen based on trial and error and the salt form selected by 
pharmaceutical chemists is based on a practical basis addressing 
cost and ease of production.[1] However, in recent times, 
intelligent design for salt selection process is more favourable,[2] 
and it is estimated that more than half of all drug molecules used 
in medicine are now marketed as salts.[3] Overall, sodium salts are 
amongst the most abundant salt forms, only surpassed by 
hydrochloride salts of basic APIs.[4]  
Connected to the improved water solubility, salts, and 
especially sodium salts, show hygroscopicity[5] and an increased 
possibility of the formation of hydrated crystal forms.[1, 4a, 6] These 
modifications include water molecules as an integral part of the 
crystal lattice.[7] Due to thermodynamic reasons, hydrates have 
the lowest solubility in water of all solid forms of a specific 
compound,[6] and thus potentially counteract the benefits of the 
initial salt formation. In addition, the presence of water in the 
crystal lattice has been shown to increase molecular mobility and 
lead to a higher reaction rate in the solid state, leading to 
enhanced chemical degradation of drug compounds.[8] Crystalline 
hydrates are classified into three groups: isolated site hydrates 
incorporate the water molecules individually or in small clusters, 
whilst channel hydrates have the structural feature of water-filled 
pores or sheets.[9] The third class of metal-associated hydrates is 
especially important for pharmaceutical sodium salts, as the water 
molecules coordinate to metal centres in the crystal structure and 
the resulting hydrated crystal form can show high or very high 
stability against dehydration.[10]  
Even though pharmaceutical sodium salts are well 
established, manifold challenges can occur during the 
manufacturing stage. Disproportionation of the salt into the 
neutral API and an inorganic sodium salt in the presence of water 
can cause stability issues of the API during formulation,[11] as has 
been shown for furosemide salts[12] as well as for ifetroban 
sodium.[13] The opposite effect of spontaneous salt formation can 
be triggered by humidity within the final formulation: One example 
for this is piroxicam, which during wet granulation in the presence 
of basic salts such as sodium carbonate or calcium phosphate 
undergoes spontaneous salt formation. Whilst the dissolution 
behaviour of piroxicam is not impacted by this change in solid-
state form, the closely related lornoxicam shows a considerable 
increase in solubility jeopardizing the patient’s safety.[14] However, 
the solid solution of amorphous indomethacine with its sodium salt 
revealed a substantial stabilizing effect of the salt on the 
amorphous material.[15] This is particularly interesting in the case 
of very low solubility presented in drug compounds, as the 
amorphous form will have a higher solubility than any crystalline 
modification.[16] Hydrated sodium salts can also offer an 
advantage from a manufacturing point of view; for example, 
diclofenac sodium tetrahydrate shows an improved flowability 
within the powder bed than its anhydrous counterpart,[17] which 
simplifies industrial processes such as mixing, tableting and 
capsule filling. 
The current European Pharmacopoeia 9.0[18] monographs 79 
pharmaceutically active small organic compounds as their  
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Figure 1. Powder X-ray diffraction (PXRD) trace of the different DTS hydrate 
forms. Experimental patterns in black, patterns calculated from single crystal 
structures in grey. 
sodium salt, of which 13 show such high stability and/or 
prevalence that the hydrate is individually monographed or even 
the solely monographed material. 
Due to their enhanced interaction with water, sodium salts can 
form multiple hydrated crystal forms. Sodium deoxycholate shows 
an intriguing variety of hydrates ranging from dihydrate to tetra- 
and even octahydrate.[19] The monographed creatine phosphate 
disodium salt exists in four interconverting hydrates ranging from 
1.5 to 7 molar equivalents of water.[20] A comparably high 
hydration has been shown for cromolyn sodium, another disodium 
salt, which forms a non-stoichiometric hydrate incorporating 
between 5 and 8 molar equivalents of water.[21] The trend of high 
water inclusion in disodium salts is further corroborated by 
pemetrexed disodium heptahydrate[22] and disodium pamidronate 
pentahydrate, both monographed as these hydrates in the 
European Pharmacopoeia. Nedocromil disodium can exist in a 
heptahemi hydrate (7.5 molar equivalents of water per drug 
compound), a trihydrate, a monohydrate and an amorphous form 
that can contain between 1.5 and 3 molar equivalents of water.[23] 
Due to the lower number of coordination sites, monosodium 
salts show lower hydration levels. They reveal, however, a 
seemingly equal potential for complexity of hydrated crystal forms. 
Cefazolin sodium, as an example, is reported to form a 
pentahydrate, which is well characterized.[24] However, there are 
hints towards additional sesqui- and monohydrated forms. 
Diclofenac sodium exists in a pentahydrate, two polymorphic 
tetrahydrates and a trihydrate.[25] Naproxen sodium, finally, 
crystallises in a tetrahydrate, two polymorphic dihydrates and a 
monohydrate.[26] 
Considering the problems that can be encountered with 
hydrate formation of API sodium salts, it is surprising that for the 
majority of the publications describing the crystal structure of the 
predominant phase of these compounds, crystallisation 
procedures in the case of patent literature, and solubility and  
 
 
Figure 2. Sorption/desorption isotherms of the commercial sample of DTS. 
Starting point is at 40% relative humidity (RH) following a sorption step, then 
desorption to 0% RH, and finally a sorption up to 90% RH again. 
dissolution rate have been published. However, many of the 
pharmaceutical sodium salts have not been fully characterized, or 
their characterisation not published, and thus their phase 
transition behaviour cannot inform processing and manufacturing 
steps.  
Diatrizoic acid is a radiocontrast agent that is monographed in 
the European[18] and the United States Pharmacopoeia[27] either 
as free acid or its meglumine or sodium salt. Whilst we have 
reported the solid-state characteristics of the free acid in detail,[28] 
with a wide variety of hydrates, anhydrous crystal forms and 
solvates, and the disodium salt ethanol solvate,[29] the sodium salt 
has not yet been investigated in depth. The presence of a 
tetrahydrate of the salt is reported by Tønnesen et al.[30] whilst we 
have found this form to incorporate 4.5 molar equivalents of water 
per salt unit.[31] The X-ray and neutron crystal structures show that 
most water is coordinated to the sodium cations, but there are 
channels in the structure through which the water can potentially 
freely diffuse in and out. Due to this interesting structure and the 
surprising supramolecular interactions in the free acid, we now 
report the solid-state behaviour of diatrizoic acid monosodium salt. 
Results and Discussion 
The crystal forms 
This study showed that DTS can exist in at least five different 
hydrated crystal forms ranging from 0.3 to 8 molar equivalents of 
water per molecular unit. Powder X-ray diffraction shows all of 
them to be distinctly different crystal forms (Fig. 1). Only three of 
these (Hy8, Hy1 and Hy0.5-3.5) crystallise directly from solution, 
whilst the other two result from conversion of another form 
induced either by humidity or heating. In addition, a methanol 
trisolvate and a mixed DMSO/H2O monosolvate directly 
crystallise from the respective solvents. An unsolvated crystal 
form could not be identified. 
  





Figure 3. High resolution dynamic vapour sorption (DVS) isotherm of the 
transition between Hy8 and Hy4. The grey line represents desorption curve, the 
black line sorption. 
The hydrates 
The dynamic vapour sorption (DVS) isotherm of the amorphous 
commercial sample shows that the sample takes up a maximum 
of 22.76% of its weight over the range from 0 to 90% relative 
humidity (Fig. 2). At the same time, the amorphous material 
undergoes crystallisation (see ESI Figure S1). The weight gain 
corresponds well to a stoichiometry of 8 molar equivalent of water 
per DTS unit (calculated weight change 22.67%), thus 
representing an octahydrate (Hy8). As described, it is very 
unusual for a mono-sodium salt to be this highly hydrated. The 
octahydrate can also be obtained by slurry conversion of the 
commercial form in water, which results in the formation of thin 
plates. The powder X-ray diffractogram of these plates is 
considerably different to the known tetrahydrate (Hy4), even 
though the platy habit leads to preferred orientation (Fig. 1). 
However, most of the observed peaks are different to the 
calculated pattern of Hy4 based on the neutron structure.[28b]. 
Thermogravimetric (TG) analysis of Hy8 shows a large 
dehydration step with the weight loss of 37.7% (Fig. S2). This 
weight loss is not purely dehydration, as the sample was prepared 
as paste with surplus mother liquor to ensure full hydration of the 
octahydrate. The dehydration up to 150 °C (Fig. S3) reveals a 
two-step desolvation profile, even though no intermediate 
equilibrium is reached. Weight loss starts immediately with a 
slope of -0.3% weight change per °C in the range from 22.6 °C to 
63.9 °C. The weight loss between these temperatures sums up to 
12.81% and can be attributed to the evaporation of the mother 
liquor and surface-bound solvent. After this first weight loss, the 
slope becomes steeper (-0.5% per °C) between 63.9 °C to 
110.1 °C. The second weight loss equals 22.56%, which 
corresponds to 7.963 molar equivalents of water and thus the 
desolvation of intact Hy8. This two-step profile was confirmed with 
differential scanning calorimetry (DSC), which shows two 
overlapping endothermic events corresponding to the events 
observed in the TG trace (Fig. S3).  
Desorption of Hy8 by reducing the humidity leads to the 
formation of the tetrahydrate Hy4 below 50% RH (Fig. 2), as was 
confirmed by powder X-ray diffraction (PXRD, Fig. 1). Even  
 
Figure 4. Humidity controlled PXRD patterns starting from Hy8 at 90% RH and 
passing through the transition to Hy4. 
though the powder pattern of this form show resemblance to the 
pattern calculated from the single crystal structure we have 
published earlier, this crystal form suffers from pronounced 
preferred orientation and the presence of a phase transition 
between the temperature of the powder and the single crystal 
measurements (300 K vs. 120 K) cannot be unambiguously ruled 
out.  
Hy4 could also be obtained by storing the commercial sample 
in aqueous slurry and drying the powder at room conditions. This 
hydrate cannot be obtained by direct crystallisation but only by 
dehydration of Hy8. Thus, its habit resembles that of Hy8 (Fig. S4). 
Surprisingly, the crystals of Hy4 are perfectly translucent and do 
not show any signs of pseudomorphosis, indicating the close 
structural relationship of these two highly hydrated crystal forms, 
and a single-crystal-to-single-crystal transition. High-resolution 
DVS shows the reversibility of the transition between Hy8 and Hy4 
(Fig. 3). Above 50% RH, Hy8 is stable but releases almost 0.5 
molar equivalents of its crystal water, which points towards the 
presence of channels within the crystal structure, from which the 
water can diffuse comparably freely depending on the 
environmental water pressure, i.e. the relative humidity. Below 
50% RH, the sample releases a further 2.3 molar equivalents of 
water in a steep step. At 43% RH, the abrupt weight loss levels 
off but a further 0.4 molar equivalents of water is released until 
reaching 30% RH. The final water content of Hy4 is verified as 4.5 
molar equivalents at 30% RH by DVS. This continuous water 
release is characteristic for non-stoichiometric hydrates, for which 
the water content solely depends on the water pressure of the 
surrounding atmosphere.[7] The non-stoichiometric character of 
the phase transition is corroborated by humidity-controlled PXRD 
(Fig.4). The peak positions of the initial octahydrate shift to the 
higher diffraction angles and thus smaller d spacing. There is no 
abrupt change between peak positions or peaks growing into the 
patterns, which would indicate a stoichiometric transition to a 
novel crystal form. It is clearly visible that the peaks become 
broader and less intense at lower RH levels, which indicates loss 
of crystallinity during the water release. The lower crystallinity also 
explains the hysteresis observed in the hydration of Hy4 to Hy8.  





Figure 5. High resolution DVS of the dehydration of Hy4. Insert represents the 
mass change (dm), respective RH levels and mass change rate (dm/dt) of the 
steps below 5% RH. 
Generally, the presence of a hysteresis would point towards a 
stoichiometric hydrate, for which the hydration and dehydration 
steps are kinetically controlled. Non-stoichiometric hydrates do 
not show the kinetic delay, as the water from the environment can 
freely diffuse in and out of the features of the crystal structure, and 
the sorption and desorption isotherms follow the exact same 
trace.[32] However, the partial loss of crystallinity of Hy4 after the 
transition introduces a kinetic element, i.e. recrystallization, into 
the hydration, which leads to this event being delayed to 55% RH, 
above which a rapid water uptake leads to Hy8.  
Storing Hy4 between 40 and 10% RH leads to only a slight 
variation in water content between 4.5 and 4 molar equivalents of 
water. It is thus likely that the structure of Tønnesen et al.[30] has 
been measured at the lower end of this humidity spectrum and 
therefore resulted in four water molecules being refined. Below 
10% RH, the remaining water is released (Fig. 2). High-resolution 
DVS of this transition (Fig. 5) shows that a step-like dehydration 
takes place below 4% RH, in which the sample loses 7.8% of its 
weight (2.76 molar equivalents of water). This mass loss leads to 
an intermediate monohydrate, which is stable at 2% RH but 
undergoes a further mass loss below this humidity. Unfortunately, 
this transition could not be followed by humidity-controlled PXRD, 
as the sample shows too low crystallinity to make out distinct 
peaks (Fig. S5). It is not clear whether the sample completely 
amorphises or is of too low crystallinity and appears X-ray 
amorphous in this experiment. From the DVS data, however, it is 
conclusive that this intermediate is indeed a crystalline phase, as 
the mass of the sample is in equilibrium at 2% RH, whilst this is 
not reached at 1% RH (Fig. 5 insert). At the lower humidity, the 
sample is in the process of releasing the remaining incorporated 
water; however, the mass step is not at its final value, as clearly 
shown by the remaining slope in the dm/dt curve. Even though 
only existing at an extremely narrow humidity range, the 
monohydrate does not represent a kinetic intermediate, as the 
crystal form is clearly stable over six hours (potentially longer) 
under these conditions, which is the time that this step has taken 
in the measurement. 
 
 
Figure 6 Packing representation of the single crystal structure of Hy1. For this 
and all following structural representations, anisotropic displacement 
parameters are drawn at 50% probability, and the colour code is carbon grey, 
nitrogen blue, oxygen red, iodine purple, sodium cyan and hydrogen light grey. 
The sorption of the completely dehydrated sample leads to a 
further hydrated form, which contains between 0.3 and 1 molar 
equivalents of water (Hy0.3-1) and takes up this amount in a very 
linear manner between 1 and 40% RH (Fig. 5 and S6). It is not 
conclusive from the data, especially considering the low 
crystallinity of the sample and thus lack of clear humidity-
controlled PXRD patterns, whether this hydrate is stoichiometric 
or non-stoichiometric in nature.  
The hydrate Hy0.3-1 obtained in the DVS could be reproduced 
by two different experimental routes. Firstly, a sample of the 
octahydrate was dried at 25 °C in dry nitrogen flow over ten hours 
using TG to directly mimic the conditions of the DVS. Secondly, 
Hy8 was dehydrated by TG at 150 °C for ten minutes. The 
resulting materials show the same PXRD patterns (Fig. 1), and 
even though the peaks have low intensity, their positions are 
distinctly different to those of Hy8 and Hy4. Both samples showed 
a comparable weight loss of approximately 1% corresponding to 
0.4 molar equivalents of water after being exposed to 
environmental humidity. 
Upon sorption above 40% RH, Hy0.3-1 takes up water in a slow 
manner and transforms directly into Hy8. The slow transition is 
reminiscent of the transition of Hy4 to Hy8 and presumably 
hampered by the low crystallinity of the sample and potential 
amorphous fraction introducing a kinetic component to the event. 
This conclusion is further corroborated by humidity-controlled 
PXRD (Fig. S7), which shows a slow transition from the X-ray 
amorphous sample to higher crystallinity at higher humidity, i.e. 
when the sample transforms into Hy8. 
To obtain the intermediate hydrated forms through another 
pathway, a full crystallisation screening was conducted. The 
predominantly crystallising form is another hydrate, which forms 
needle-shaped crystals (Fig. S4). TG analysis shows 3.26% 
weight loss (Fig. S2), which corresponds to 1.1 molar equivalents 
of water thus classifying the novel crystal form as a monohydrate 
(Hy1). PXRD analysis shows clearly different peak positions to 
the other hydrated forms (Fig. 1). Single crystals of Hy1 grown in 
slowly cooled ethanol solution crystallise in the tetragonal space 
group I4cm with half a molecular unit in the asymmetric unit. The 
packing shows both linear coordination polymeric strands as well  





Figure 7 DVS isotherm of Hy1 starting form room conditions down. Isotherm is 
normalised to lowest point of the measurement. 
as hydrogen bonding motifs running on parallel along the unique 
c axis (Fig. 6). The sodium cations coordinate to the deprotonated 
acid, as is also the case for Hy4, whilst the coordination scheme 
between the two crystal forms is different. In Hy4, the carboxylate 
coordinates to the sodium ion through one oxygen atom, whilst 
the other accepts a hydrogen bond from a water molecule. In Hy1, 
one carboxylic oxygen atom likewise coordinates to one sodium 
cation, but the other instead coordinates to two more Na cations 
in the next layer along the c axis. This motif results in a square of 
alternating sodium and oxygen atoms, in which each carboxylic 
acid bonds to three sodium cations and each sodium bonds to 
three carboxylates. A fourth coordination bond of the sodium ion 
is realised by bonding to the water molecule. Surprisingly, the 
incorporated water molecule does not donate any hydrogen 
bonds to the surrounding molecules and thus acts merely as filler 
for the coordination shell and space filler for the structure. The 
diatrizoate anions show the cis conformation in which the amide 
carbonyl moieties point towards one side of the central ring and 
the amino moieties are directed to the opposite side.[28b] This 
enables catemeric hydrogen bonding between the coordination 
polymeric strands along the c axis. No halogen bonds are realised 
in this structure. Overall, the packing of Hy1 is more efficient with 
a calculated density of 2.50 vs. 2.33 g cm-3 for Hy4, which points 
towards a lower energy of the monohydrate. This is reflected in 
the dominance of Hy1 as the crystallisation result of most solution 
crystallisations (Table S1). The DVS isotherm of Hy1 is distinctly 
different to that of the transient monohydrate obtained from 
dehydration of Hy4 (Fig. 7). It is noteworthy that even though the 
water content of the directly crystallised Hy1 as determined by 
Karl-Fischer titration is slightly higher than 1 mole of water (3.75% 
corresponding to 1.375 molar equivalents of water), the same 
sample submitted to DVS measurements contains 8% of volatile 
inclusion. This could be due to a low impurity of the material, 
potentially a higher hydrate, even though no impurities were 
detected by PXRD (Fig. 1). It is also possible that this hydrate 
shows non-stoichiometric characteristics and can contain a higher 
amount of water at higher humidity. The DVS isotherm starting 
from 40% RH (room conditions) towards lower humidity shows a 
gradual release of the incorporated solvent with an increase in  
 
Figure 8 DVS isotherm of Hy2.4-3.4 starting form room conditions down. Isotherm 
is normalised to lowest point of the measurement. 
rate towards 0% RH. The sorption isotherm does not follow the 
same path as the desorption, but runs in parallel at a lower weight. 
Since the atmosphere in the instrument only contains water 
vapour, it can be safely assumed that this increase in weight 
corresponds to the take-up of water. This would corroborate the 
assumption of a low fraction impurity containing either a larger 
amount of water or a heavier solvent, e.g. ethanol from the 
solution crystallisation. The sample shows an almost linear 
uptake of water over the range from 10% to 60% RH, which 
corroborates the hypothesis of this hydrate being non-
stoichiometric. Unfortunately, the sample amount of Hy1 
accessible by crystallisation is too low to perform humidity 
controlled PXRD measurements, proving this hypothesis. At 
humidity levels between 60% and 90% RH, the weight gain rate 
increases whilst the sample converts to Hy8. This is clearly shown 
by the following desorption curve, which is identical to that of the 
octahydrate. 
A second hydrated crystal form could be obtained by direct 
crystallisation. The plate-shaped crystals grow concomitantly with 
Hy1 from ethanol solution, and are distinctly different by PXRD 
(Fig. 1). TG measurements reveal a water content of 6.83%, 
which correlates with 2.6 molar equivalents of water.  
The DVS isotherm of this hydrate reveals that the sample 
contains 8.99% volatile component (3.2 molar equivalents of 
water), again at a slightly higher weight percentage when 
normalised to the lowest point of the isotherm being zero (Fig. 8). 
Upon lowering the humidity, the sample loses weight in a 
continuous manner, which speeds up between 20 and 10% RH 
whilst stabilising again between 10 and 0% RH. The lowest water 
content of this hydrate is 0.5 molar equivalents. The sorption 
isotherm follows an almost identical path to the desorption proving 
the non-stoichiometric character of this hydrate. The highest 
water content of this form is reached with 9.75% (3.44 molar 
equivalents of water) at 60% RH, thus the ranges of this hydrate 
are between 0.5 and 3.5 molar equivalents of water (Hy0.5-3.5). 
Above 60% RH, the sample takes up water at a higher rate and 
transforms to the octahydrate. Almost full hydration of Hy8 is 
reached indicating only minor traces of impurities. The second 
desorption isotherm traces exactly that of Hy8.  






Figure 9 Packing of the crystal structure of Hy0.5-3.5 along the crystallographic a 
axis with clearly visible pores.  
Due to the small size of the individual crystals, diffraction data of 
Hy0.5-3.5 were collected on the synchrotron beamline I19 at 
Diamond Light Source, Oxfordshire, UK. The structure solution 
shows that this hydrate crystallises in the tetragonal space group 
I41/a with one molecular unit in the asymmetric unit. Surprisingly, 
only 1.6 molar equivalents of water can be refined, even though 
additional electron density points towards more disordered water 
in this structure. As in the other hydrates, the carboxylate moieties 
coordinate to the sodium cations; however, in Hy0.5-3.5 only one of 
the oxygen atoms is involved in the coordination. The resulting 
motif is a slightly twisted cube with alternating sodium and oxygen 
atoms at its corners (Fig. S8). Each sodium cation furthermore 
coordinates to a water oxygen atom, whilst two half-occupied 
water positions bridge two faces of the cube. Comparable to Hy4, 
the second oxygen atom of the carboxylate moiety is involved in 
hydrogen bonding with a coordinate water molecule (donor-
acceptor heavy atom distance: 2.74(2) Å). The hydrogen bonding 
motif found between the diatrizoate ions resembles that of Hy4: 
centrosymmetric dimers show hydrogen bonding between one 
amide N-H moiety to the non-coordinated oxygen atom of the 
carboxylate, whilst the N-H of the second amide hydrogen bonds 
to a third diatrizoate amide carbonyl. The latter hydrogen bond 
leads to spirals along the 41 axis. Halogen bonds involving the 
iodine atoms are realised with both amide carbonyl oxygens as 
well as to the disordered water.  
The structure contains a 2-dimensional network of solvent-
accessible channels, which run along the crystallographic a and 
b axes (Fig. 9). These channels are the reason for the non-
stoichiometric behaviour observed by DVS, as water from the 
environment can diffuse in and out of the structure without 
changing the overall scaffold. This hypothesis is corroborated by 
the remaining electron density, which is located within the 
channels and points towards additional disordered water 
molecules. Compared to Hy4 and Hy1, Hy0.5-3.5 has with 
2.14 g cm-3 the lowest density, which may be due to missing 
modelled water. However, the low density points towards the 
highest energy and thus the lowest stability of this crystal form. 
This is corroborated by the occurrence of Hy0.5-3.5 in only one 
crystallisation experiment and even then only concomitantly with 




Figure 10 1D coordination polymers of the (a) methanol and (b) DMSO/H2O 
solvates of DTS.  
The solvates 
In addition to the hydrated crystal forms, two solvates of DTS were 
found to crystallise from methanol and DMSO, respectively (Fig. 
S9). The methanol solvate shows a weight loss of 13.03% by TG, 
which corresponds to 3 molar equivalents of methanol (calculated 
weight loss 13.113%, Fig. S10). It is not surprising that such a 
high number of methanol molecules are incorporated by DTS, 
especially considering the complex hydration behaviour as 
discussed above, as methanol is only slightly bigger than water 
and can coordinate to the sodium cation in a comparable manner. 
The weight loss of the methanol solvate starts already at room 
temperature indicating the low stability of this solvate, and it is 
likely that desolvation occurs under dry conditions. The low 
stability is additionally reflected by the crystallisation of Hy1 from 
methanol by evaporation under ambient conditions 
(approximately 40% RH). Single crystals of the methanol solvate 
suitable for X-ray diffraction grew in a slowly cooled methanol 
solution. The structure crystallises in the monoclinic space group 
P21/c with one molecular unit in the asymmetric unit. Three 
solvent molecules coordinate to the sodium cation, proving this 
structure to be a trisolvate. In addition, the carboxylate group 
coordinates to a sodium ion, as well as one amide carbonyl. The 
latter interaction is not realised in any of the hydrate structures 
and leads to 1D coordination polymeric chains along the 
crystallographic b axis (Fig. 10a). The second amide group 
accepts a hydrogen-bond from the amide N-H moiety of a 
neighbouring anion, which connects the polymeric chains with 
each other. Two of the methanol molecules are hydrogen-bonding 
to the carboxylate moiety of the anion, whilst the third methanol 
donates a hydrogen bond to a neighbouring methanol molecule. 
There are no clear channels for the solvent to diffuse through and 
its hydrogen-bonded nature in this structure does not explain the 
relatively low stability of this solvate. 
Precipitation of DTS from DMSO solution with antisolvent 
yields a metastable solvate containing one molecule of DMSO 
and water each per DTS, which is confirmed by the experimental 
weight loss by TG (Fig S10). This mixed solvate crystallises in the 
orthorhombic space group Pca21 with one molecular unit in the 
asymmetric unit. The sodium cation has the lowest coordination 
number with only four oxygen atoms (one from each solvent, two 
from diatrizoate) interacting with it. The coordination of two 
oxygen atoms of the anion through the carboxylate as well as one 
amide carbonyl leads to the presence of 1D coordination 
polymeric chains comparable to the methanol solvate (Fig. 10b). 
However, the geometry of the chain in this solvate is more open 
and linear due to the lack of hydrogen bonds, which in the case 
of the methanol solvate leads to a spiral with a short pitch length.  





Figure 11 Schematic representation of the crystal forms and transformation 
pathways of DTS.  
The open chains of the DMSO/H2O 1:1 solvate pack closely on 
top of each other leading to a herringbone packing. Whilst the 
incorporated water is donating hydrogen bonds to both the 
carboxylate and the amide moiety of the anion, the DMSO 
molecules are only coordinated to the sodium ion through their 
oxygen atoms and thus show higher motion around this hinge 
(detected as larger ADPs, Fig. S11). Surprisingly, though, the two 
different solvent species leave the crystal lattice at the same time, 
as observed by TG, showing that the initial crystal structure is not 
stable without either of the guest components and collapses. 
Even though this mixed solvate is metastable, it gives another 
indication of the high attraction of DTS to water. 
Conclusions 
Diatrizoic acid monosodium salt exists in at least five hydrated 
crystal forms and two solvates. The hydrates range in water 
content from 0.3 to 8 molar equivalents (Fig. 11). Three of them 
(Hy8, Hy1 and Hy0.5-3.5) crystallise directly from solution whilst the 
remaining hydrates (Hy4 and Hy0.3-1) are obtained by dehydration 
of Hy8 only. At high humidity levels, all hydrates convert to Hy8. 
The solvates contain three moles of methanol or one mole each 
of DMSO and water in a mixed solvate. Structural analysis of 
three hydrates and both solvates show a strong involvement of 
the sodium cation but additional stabilising hydrogen bonding. 
The monohydrate and both solvates show 1D coordination 
polymers through interaction between the organic anion and the 
sodium ion. Except for Hy4, all incorporated water is directly 
coordinated to the cation and hydrogen bonds to other moieties 
of the crystal structure. No anhydrous crystal form of DTS could 
be identified. 
This intriguing pharmaceutical salt exemplifies the importance 
of in-depth data on the solid-state behaviour of a sodium salt 
under variable humidity conditions. It is obvious that the 
incorporation of water into the crystal structures stabilises them, 
as apart from the methanol solvate, no water-free modification 
could be obtained. The interchanging characteristics of the 
hydrates additionally highlight the importance of humidity-
controlled experiments to fully understand pharmaceutical sodium 
salts before formulation and manufacturing. DTS can contain 
between 0.3 and 8 molar equivalents of water depending on the 
crystal form and relative humidity, which will have an impact on 
dose, solubility and uniformity of any produced solid formulation. 
The frequent phase changes upon varying the humidity, as well 
as potential amorphisation upon release of all incorporated water, 
presents an additional complication for manufacturing and 
stability of the final formulation. Even though DTS is not currently 
marketed as a solid, it is a good model compound to show up the 
potential hazards of sodium salts in water-containing 
environments and advocates for full and in-depth characterisation 
of other sodium salts used pharmaceutically. 
Experimental Section 
Materials 
Sodium diatrizoate (≥98.0%) (DTS) was purchased from Sigma-Aldrich 
and used unrefined. Acetone (≥99.8%), acetonitrile (≥99.9%), n-amyl 
alcohol (≥99.0%), 1-butanol (≥99.4%), 2-butanol (≥99.5%), dimethyl 
sulfoxide (DMSO) (≥99.9%), 1,4-dioxane (≥99.0%), N,N-dimethyl 
formamide (anhydrous 99.8%), dichloromethane (≥99.8%), ethyl acetate 
(anhydrous ≥99.8%), 2-butanone (ethyl methyl ketone) (≥99.0%), hexane 
(anhydrous 95.0%), methanol (≥99.6%), 1-propanol (anhydrous 99.5%), 
2-propanol (anhydrous 99.5%), tetrahydrofuran (anhydrous 99.9%), were 
purchased from Sigma-Aldrich, diethyl ether (99.99%) and chloroform 
(99.98%) were purchased from Fisher chemicals, ethanol (≥99.8%) was 
purchased from Fluka, while nitromethane (96.0%) was purchased from 
Acros organics. All solvents were used without further purification. The Karl 
Fisher titration reagent used was HYDRANAL®- Coulomat AG (Sigma-
Aldrich Laborchemikalien GmbH, Seelze, Germany)  
Methods 
Crystallisation: Slow and fast cooling, evaporation and precipitation 
crystallisation methods were used. Approximately 20 mg of DTS was used 
in each of the crystallisation experiments. For the cooling experiments, 
DTS was dissolved in sufficient amounts of each of the 21 solvents to 
produce a hot saturated solution. This was then cooled at different rates; 
slow cooled samples were left to cool to room temperature in an insulating 
wooden block while fast cooled samples were quenched in an ice and 
water bath. For evaporation, the material was dissolved in sufficient 
solvent to produce an undersaturated solution and left to evaporate at 
ambient conditions. Precipitation was conducted by producing a hot 
saturated solution and adding dichloromethane or diethyl ether as 
antisolvents, depending on miscibility. In the case of the fast cooling and 
precipitation experiments, the crystals were immediately removed from 
solution once they formed, whereas evaporation and slow cooling 
experiments were left for 24 hours before analysis. 
Thermogravimetric analysis scans were carried out with a Q 500 (TA 
Instruments, New Castle, DE, USA). Nitrogen served as the purge gas at 
a flow rate of 60 mL min-1. Samples of 1 to 5 mg were accurately weighed 
(±0.01 mg) into 50 μL platinum pans. A heating rate of 10 °C min-1 was 
used and each sample was heated from 25 °C to 300 °C.  
Differential scanning calorimetry scans were carried out on Q 2000 (TA 
Instruments, New Castle, DE, USA). Nitrogen served as the purge gas at 
a flow rate of 60 mL min-1. Approximately 1 to 5 mg of the sample were 
accurately weighed (±0.01 mg) using a microbalance (Sartorius, Göttingen, 
Germany), loaded into aluminium standard pans (TA Instruments, New 




Castle, DE, USA) and sealed. A heating rate of 10 °C min-1 was used and 
each sample was heated from 25 °C to 300 °C. 
Karl Fischer titrations for water content determination were performed 
using a Metrohm AG 899 coulometer titrator (Metrohm Ltd., Herisau, 
Switzerland). The medium was titrated to dryness before each analysis. 
Between 5 and 10 mg of sample was weighed (±0.1 mg) using a Kern ABJ 
200-4NM analytical balance (Kern & Sohn GmbH, Balingen, Germany) for 
each analysis. 
Gravimetric moisture sorption analysis was carried out using a humidity 
and temperature controlled dynamic vapour sorption (DVS) apparatus, 
(Surface Measurement Systems, Boro Labs Ltd. Aldermaston, Berks, 
U.K.) equipped with Cahn D200 digital recording ultra-microbalance with a 
mass resolution of ±0.01 μg. Initially, samples between 10 to 15 mg were 
accurately weighed (±0.1 mg) using a Kern ABJ 200-4NM analytical 
balance (Kern & Sohn GmbH, Balingen, Germany) and then loaded in TA 
Tzero pans (TA Instruments, Switzerland). Moisture uptake and release 
cycles (reported relative to the dry weight) were monitored over a 
sorption/desorption range of 0% to 90% relative humidity (RH), with 
increments of 10% RH, at a constant temperature of 25 °C. Higher 
resolution runs with 1% RH step intervals were performed at RH at phase 
transitions points were observed. The equilibrium condition for each step 
was set to a mass constancy of ±0.01%. 
Fourier transform infra-red spectroscopy (FTIR) spectra of solid 
phases were collected on a Spectrum Two IR Spectrometers (Perkin-
Elmer, Massachusetts, U.S.A). Samples were placed on a diamond 
Attenuated Total Reflectance (ATR) accessory. Four scans were collected 
for each sample at a resolution of 2 cm-1 over a wavenumber region of 
4000 cm-1 to 600 cm-1. 
Powder X-ray diffraction (PXRD) data were obtained using an Empyrean 
powder diffractometer (PANalytical, Almelo, Netherlands) equipped with 
Cu-Kα radiation (wavelength of 1.541874 Å), graphite monochromator, 0.2 
mm fixed Soller slits and PIXcel detector. The operating tube voltage of 40 
kV and tube current of 40 mV were used. For each sample, a scan was 
conducted in the Bragg-Brentano (θ-2θ) geometry between 2 to 40° 2Θ, at 
rate of 0.5° 2Θ per minute. The samples were prepared as dry powder and 
placed on a zero-background sample holder. Humidity PXRD data were 
obtained using a D8 Discover powder diffractometer (Bruker, Coventry, 
UK) equipped with a Cu-Kα source (wavelength of 1.5406 Å), primary 
motorised slits set at 10 mm fixed sample size, Soller slits, secondary 
motorised slits set at 4° opening angle and a LynxEye detector. The 
operating tube voltage of 40 kV and tube current of 40 mA were used and 
the diffractometer was equipped with a CHC plus+ humidity chamber. The 
sample was mounted on a zero-background holder in the chamber, and all 
scans were conducted in the Bragg-Brentano (theta-2theta) geometry from 
2 to 40° 2Θ, with a step size of 0.018° 2Θ and a time per step of 0.2 
seconds. The sample was held at 25 °C and the humidity varied in steps, 
with the sample allowed to equilibrate for 2 hours at each step. For 
temperature-controlled PXRD run between humidity runs, humidity 
generation was switched off, and the temperature was varied in steps, with 
2 hours equilibration time allowed at each step. 
Single crystal X-ray diffraction data were obtained on crystals coated in 
perfluoro polyether oil and mounted on MiTeGen sample holders. The 
samples were placed directly into the pre-cooled cryostream. Datasets of 
Hy1 and the DMSO H2O solvate were collected on a D8 diffractometer 
(Bruker, Coventry, UK) operated with Mo-Kα radiation, double mirror 
monochromator and Photon detector. The methanol solvate was 
measured on an Xcalibur diffractometer (Oxford Diffraction, Oxford, UK) 
operated with graphite-monochromated Mo-Kα radiation. The dataset of 
Hy0.5-3.5 was collected on instrument I19 at the Diamond Light Source, 
Didcot, UK. The data were reduced using APEX2 software package 
(Bruker, Coventry, UK), solved with olex.solve and refined with olex.refine 
as included in the Olex2 software package.[33] All non-hydrogen atoms 
were identified from electron density maps and refined anisotropically, 
whilst hydrogen atoms were modelled in geometrically ideal positions and 
refined as a riding model. 
Hot-stage microscopy observations were carried out with a Leica DM 
2700P polarising microscope (Leica Microsystems GmbH, Wetzlar, 
Germany) equipped with THMS600 heating and freezing microscope 
stage and controller (Linkam Scientific Instruments, Tadworth, U.K.). The 
setup is completed with QICAM Fast1394 (Qimaging, British Colombia, 
Canada) colour video camera attachment, supported by Linksys32 version 
2.4.3. 
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